The gastrointestinal (GI) tract is the largest lymphoid organ in the human body and, therefore, any defects in the cellular and/or humoral immune responses may be indicators of a strong disposition to a multitude of enteric viral, bacterial, protozoan, and fungal pathogens (1). The identification of enteric pathogens in the GI tract has been especially important in patients with AIDS, where the HIV-induced immunodeficiency greatly increases the possibility of opportunistic infections (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Georgiev, V. St. (1998) Gastrointestinal infections in the immunocompromised hosts. In: Infectious Diseases in Immunocompromised Hosts, CRC Press, Boca Raton, FL, pp. 473–480.
Smith, P. D. and Janoff, E. N. (1988) Infectious diarrhea in human immunodeficiency virus infection, Gastrointerol. Clin. North Am., 17, 587.
World Health Organization. (2006) Wkly Epidemiol. Rec. (WER), 81, 97–104 [March 17, 2006].
Centers for Disease Control and Prevention (2005) Final 2005 reports of notifiable diseases, Morb. Mortal. Wkly Rep., 55(32), 880–881.
Finkelstein, R. A., Sciortino, C. V., and McIntosh, M. A. (1983) Role of iron in microbe–host interactions, Rev. Infect. Dis., 5(Suppl. 4), S759–S577.
Perry, R. D. and Brubaker, R. R. (1979). Accumulation of iron in Yersinia, J. Bacteriol., 137, 1290–1298.
Heesemann, J., Hantke, K., Vocke, T., Saken, E., Rakin, A., Stojilkovic, I., and Berner, R. (1993) Virulence of Yersinia enterocolitica is closely associated with siderophore production, expression of an iron-repressible outer membrane polypeptide of 65,000 Da and pesticin sensitivity, Mol. Microbiol., 8(2), 397–408.
Richardson, N. J., Koornhof, H. J., and Bokkenheuser, V. D. (1981) Long-term infections with Campylobacter fetus subsp. jejuni, J. Clin. Microbiol., 13(5), 846–849.
DuPont, H. L., Ericsson, C. D., Robinson, A., and Johnson, P. C. (1987) Current problems in antimicrobial therapy for bacterial enteric infection, Am. J. Med., 82(Suppl. 4A), 324–328.
Keat, A. (1983) Reiter’s syndrome and reactive arthritis in perspective, N. Engl. J. Med., 309(26), 1606–1615.
Hagensee, M. E., Benyunes, M., Miller, J. A., and Spach, D. H. (1994) Campylobacter jejuni bacteremia and Guillain-Barrè syndrome in a patients with GVHD after alogeneic BMT, Bone Marrow Transplant., 13(3), 349–351.
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., and Levy, J. S. (1989) Cross-resistance to fluoroquinolones in multiple-antibiotic resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol decreased drug accumulation associated with membrane changes in addition to OmpF reduction, Antimicrob. Agents Chemother., 33(8), 1318–1325.
Cozzarelli, N. R. (1980) DNA gyrase and supercoiling of DNA, Science, 207(4434), 953–960.
Wiedemann, B. and Heisig, P. (1994) Mechanisms of quinolone resistance, Infection, 22(Suppl. 2), S73–S79.
Segreti, J., Gootz, T. D., Goodman, L. J., Parkhurst, G. W., Quinn, J. P., Martin, B. A., and Trenholme, G. M. (1992) High-level quinoline resistance in clinical isolates of Campylobacter jejuni, J. Infect Dis., 165(4), 667–670.
Gootz, T. D. and Martin, B. A. (1991) Characteristics of high-level quinolone resistance in Campylobacter jejuni, Antimicrob. Agents Chemother., 35(5), 840–845.
Nikaido, H. and Rosenberg, E. Y. (1983) Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins, J. Bacteriol., 153(1), 241–252.
Cohen, S. P., Hooper, D. C., Wolfson, J. S., Souza, K. S., McMurry, L. M., and Levy, S. B. (1988) Endogenous active efflux of norfloxacin in susceptible Escherichia coli, Antimicrob. Agents Chemother., 32(8), 1187–1193.
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., Lillibridge, S., Osterholm, M. T., O’Toole, T., Parker, G., Perl, T. M., Russell, P. K., Swerdlow, D. L., and Tonat, K. for the Working Group on Civillian Defense (2001) Botulinum toxin as a biological weapon: medical and public health management, N. Engl. J. Med., 285(8), 1059–1070.
Schuchat, A., Deaver, K. A., Wenger, J. D., Plikaytis, B. D., Mascola, L., Pinner, R. W., Reingold, A. L., and Broome, C. V. (1992) Role of food in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group, J. Am. Med. Assoc., 267, 2041–2045.
Nataro, J. P. and Kaper, J. B. (1998) Diarrheagenic Escherichia coli, Clin. Microbiol. Rev., 11, 142–201.
Trabulsi, L. R., Keller, R., and Tardelli Gomes, T. A. (2002) Typical and atypical enteropathogenic Escherichia coli, Emerg. Infect. Dis., 8(5), 508–513.
Sperandio, V., Kaper, J. B., Bortolini, M. R., Neves, B. C., Keller, R., and Trabulsi, L. R. (1998) Characterization of the locus of enterocyte effacement (LEE) in different enteropathogenic Escherichia coli (EPEC) and Shiga toxin-producing Escherichia coli (STEC) serotypes, FEMS Microbiol. Lett., 164, 133–139.
Gasser, C., Gautier, E., Steck, A., Siebenmann, R. E., and Oechslin, R. (1955) Hämolytisch-urämische syndrome: bilaterale nierenrindennekrosen bei akuten erworben hämolytischen anämien, Schweiz. Med. Wochenschr., 85(38–39), 905–909.
Leaf, A. N., Laubenstein, L. J., Raphael, B., Hochster, H., Baez, L., and Karpatkin, S. (1988) Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection, Ann. Intern. Med., 109(3), 194–197.
Beris, P., Dunand, V., Isoz, C., and Reynard, C. (1990) Association of thrombotic thrombocytopenic purpura and human immunodeficiency virus infection, Nouv. Rev. Fr. Hematol., 32(4), 277–280.
Johnson, J. R. (2000) Shigella and Escherichia coli at the crossroads: Machiavellian masqueraders or taxonomic treachery? J. Med. Microbiol., 49, 583–585.
Linnenborg, M., Weintraub, A., and Widmalm, G. (1999) Structural studies of the O-antigen polysaccharide from the enteroinvasive Escherichia coli O164 cross-reacting with Shigella dysenteriae Type 3, Eur. J. Biochem., 266, 460–466.
Cheasty, T. and Rowe, B. (1983) Antigenic relationships between the enteroinvasive Escherichia coli O-antigens O28c, O112ac, O124, O136, O143, O144, O152, and O164 and Shigella O-antigens, J. Clin. Microbiol., 17, 681–684.
Nataro, J. P., Steiner, T., and Guerrant, R. L. (1998) Enteroaggregative Escherichia coli, Emerg. Infect. Dis., 4(2), 251–261.
Sansonetti, P. I., d’Hauteville, H., Formal, S. B., and Toucas, M. (1982) Plasmid-mediated invasiveness of “Shigella-like Escherichia coli, Ann. Microbiol. (Paris), 133(3), 611–617.
Brenner, D. J., Fanning, G. R., Skerman, F. J., and Falkow, S. (1975) Polynucleotide sequence divergence among strains of Escherichia coli and closely related organisms, J. Bacteriol., 109, 953–965.
Whittam, T. S., Ochman, H., and Selander, R. K. (1983) Multilocus genetic structure in natural populations of Escherichia coli, Proc. Natl. Acad. Sci. U.S.A., 80, 1651–1755.
Hartl, D. L. and Dykhuizen, D. E. (1984) The population genetics of Escherichia coli, Annu. Rev. Genet., 18, 31–68.
Pupo, G. M., Kariolis, D. K. R., Lan, R., and Reeves, P. R. (1997) Evolutionary relationships among pathogenic and nonpathogenic Escherichia coli strains inferred from multilocus enzyme electrophoresis and mdh sequence studies, Infect. Immun., 65, 2685–2692.
Ochman, H., Whittam, T. S., Caugant, D. A., and Selander, R. K. (1983) Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella, J. Gen. Microbiol., 129, 2715–2726.
Widdowson, M.-A., Monroe, S. S., and Glass, R. I. (2005) Are novoviruses emerging? Emerg. Infect. Dis., 11(5), 735–737.
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Breese, J. S., Shapiro, C., Griffin, P. M., and Tauxe, R. V. (1999) Food-related illness and death in the United States, Emerg. Infect. Dis., 11(5), 607–625.
Clarke, M. B., Hughes, D. T., Zhu, C., Boedeker, E. C., and Sperandio, V. (2006) The QseC sensor kinase: a bacterial adrenergic receptor, Proc. Natl. Acad. Sci. U.S.A., 103(27), 10420–10425.
Bakardjiev, A. I., Theriot, J. A., and Portnoy, D. A. (2006) Listeria monocytogenes traffics from maternal organs to the placenta and back, PLoS Pathogens, 2(6), e80.
Crane, J. K., Choudhari, S. S., Naeher, T. M., and Duffey, M. E. (2006) Mutual enhancement of virulence by enterotoxigenic and enteropathogenic Escherichia coli, Infect. Immun., 74(3), 1505–1515.
Palmer, C., Bik, E. M., Eisen, M. B., Eckburg, P. B., Sana, T. R., Wolber, P. K., Relman, D. A., and Brown, P. O. (2006) Rapid quantitative profiling of complex microbial populations, Nucleic Acids Res., 34(1), e5.
Dong, M., Yeh, F., Tepp, W. T., Dean, C., Johnson, E. A., Janz, R., and Chapman, E. R. (2006) SV2 is the protein receptor for botulinum neurotoxin A, Science, 312(5773), 595–596.
Enteric Vaccines for Pediatric Use. (2004) NIAID Workshop Report, Airlie Center, Warrenton, VA, April 24–26, 2004.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Georgiev, V.S. (2009). Enteric Diseases. In: Georgiev, V.S. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-297-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-60327-297-1_9
Publisher Name: Humana Press
Print ISBN: 978-1-60327-296-4
Online ISBN: 978-1-60327-297-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)